What MedTech SuperConnector does

MedTech SuperConnector (MTSC) is a UK-based accelerator programme operated from Imperial College London's Enterprise Lab that supports Early Career Researchers (ECRs) in translating medical technology research into commercial ventures. Founded in 2019, it recruits participants from eight UK academic institutions and three science business incubators and runs a 6-month part-time intensive venture-building programme delivered in a track-based format with leading institutional and industry partners.

The programme does not develop proprietary technology. Its core "product" is the accelerator itself, comprising entrepreneurship training co-developed with Imperial College London Business School, access to funding, mentorship from clinicians, health economists, regulatory experts and industry advisors, and connections to investor networks. Documented portfolio ventures include Bone Cap (a musculoskeletal implant for amputees, late pre-clinical), AGA Nanotech (a non-antibiotic antimicrobial platform at TRL 4), and ClearXview (generative AI that converts 2D X-rays into 3D orthopaedic images, pre-seed).

MTSC is funded rather than revenue-generating: it does not charge participants, has no disclosed revenue, and operates under institutional support from Imperial College London and a network of charity, corporate and research partners. The organisation is led by Head of MTSC Hiten Thakrar and Programme Manager Ashley Mah, and is publicly soliciting additional sponsors to extend its reach and develop new MedTech themes.

Name

MedTech SuperConnector

Legal name

MedTech SuperConnector

Website

https://medtechsuperconnector.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

MedTech SuperConnector is an Imperial College London-hosted accelerator programme running a 6-month part-time venture-building course for UK Early Career Researchers commercialising medical technology innovations, supported by charity, corporate and academic partners.

Ownership category

akta.pro rank

Product category

Medical Technology Accelerator

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Health & Medical Research Grantmaking Foundations (BPAGAKAL)

akta.pro secondary industries

Research & Science Grantmaking Foundations (BPAGAKAI), Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)

Keywords

• Medical technology accelerator
• Healthcare innovation program
• Early career researcher support
• Medtech venture building
• Healthcare startup program

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Program Funding: MedTech SuperConnector operates as a funded accelerator program supported by Imperial College London and partner institutions. The program provides startups with access to world-class entrepreneurship training, funding, advisors, and industry experts without charging participants. The program actively seeks sponsors and collaborators to extend its reach and develop additional themes.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

MedTech SuperConnector (MTSC) operates a 6-month part-time intensive venture-building accelerator programme for Early Career Researchers from UK academic institutions. It provides world-class entrepreneurship training (developed with Imperial College London Business School), access to funding, advisors, clinicians, regulatory experts, and industry networks to help researchers translate medical technology innovations into commercial ventures.

Product overview

MedTech SuperConnector (MTSC) operates as a single, unified accelerator programme rather than a multi-product platform. The core offering is the 6-month part-time venture-building programme that combines entrepreneurship training developed with Imperial College London Business School, access to funding and advisors, and connections to industry experts and investor networks. The programme does not have separate modular products; all components (training, mentorship, funding access, and network connections) are integrated into the single accelerator programme designed to help early career researchers commercialize medical technology innovations.

Differentiator

Problem solved

Functional benefit

Products and services

• MedTech SuperConnector Accelerator Programme A 6-month part-time intensive venture-building programme for Early Career Researchers from UK academic institutions, designed to help translate medical technology research into commercial ventures. Includes world-class entrepreneurship training (with Imperial College London Business School), access to funding, advisors, clinicians, health economists, regulatory experts, and industry networks.
• MSK Innovation Accelerator Programme A specialized track-based accelerator cohort under the MedTech SuperConnector umbrella, focused on musculoskeletal innovation themes and delivered in partnership with leading institutions and industry players.

Quantifiable outcome

• 70+ Early Career Researchers supported from institutions across the UK
• +1 more outcomes

Named customers3 records

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• Imperial College LondoncoreStrategic or Co-development PartnerImperial College London is the primary institutional partner, hosting MedTech SuperConnector at its Enterprise Lab. The partnership provides access to world-class research facilities, academic expertise, and the broader Imperial entrepreneurial ecosystem. Digital learning content is developed with Imperial College London Business School.
• Leading Charities, Corporates, and Research InstitutionscoreStrategic or Co-development PartnerMedTech SuperConnector partners with leading charities, corporates, and research institutions to provide participants with access to essential resources, expertise, and opportunities. The network includes industry experts, clinicians, health economists, and regulatory experts.
• Eight Academic InstitutionscoreStrategic or Co-development PartnerMedTech SuperConnector combined the research and resources of eight academic institutions to create the accelerator programme. This collaboration enables recruitment of Early Career Researchers from multiple institutions across the UK.
• Three Science Business IncubatorscoreStrategic or Co-development PartnerPartnership with three science business incubators provides startups with additional support resources, mentorship networks, and facilities for early-stage venture development.
• Various Global PartnersminorStrategic or Co-development PartnerVarious global partners contribute expertise and resources to support the program's international reach and connect UK-based innovators with global market opportunities.
• Neil Roberts (South East Health Technologies Alliance)minorOthersNeil Roberts, CEO of South East Health Technologies Alliance, provides expertise in business development, market access, and medical technology commercialization based on 30+ years of senior executive experience.
• Dr Melody Ni (Imperial College London)minorOthersDr Melody Ni, Senior Research Fellow in Surgery and Cancer at Imperial College London, provides expertise in decision analysis, risk analysis, and health technology assessments, leading the HTA research stream within the NIHR London in Vitro Diagnostics Co-operative.
• Prof Anthony Bull (Imperial College London)minorStrategic or Co-development PartnerProfessor of Musculoskeletal Mechanics and leading translational researcher. Four companies have spun out from his research in implantable orthopaedic devices, wearables rehabilitation technology, surgical technology, and prostheses.
• Prof Markus Perkmann (Imperial Business School)minorStrategic or Co-development PartnerVice-Dean for Research and Faculty at Imperial Business School, academic director of Enterprise Lab, with research spanning science-based entrepreneurship and entrepreneurship within corporations.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• IndieBio: Biotech accelerator providing seed funding, mentorship, and lab access to science-based startups. Comparable to MTSC in its focus on translating deep scientific research into commercial ventures, although IndieBio takes equity and operates globally rather than as a UK university-hosted programme.
• Startupbootcamp Digital Health: Global accelerator programme focused on digital health and MedTech startups, providing mentorship, corporate partnerships, and investor access. Closely comparable to MTSC in providing structured accelerator support to early-stage medical technology ventures.

Regional players

• NHS Innovation Accelerator: UK NHS-backed accelerator supporting innovators to scale evidence-based healthcare solutions across the NHS. Closest functional peer to MTSC within the UK given its shared mission of supporting healthcare innovators with training, mentorship, and access to clinical and regulatory networks.
• DigitalHealth.London: London-based accelerator for digital health companies, delivered through a partnership of NHS, academic, and industry organisations. Comparable to MTSC as a UK-based health-innovation accelerator helping early-stage ventures navigate NHS adoption and commercialise.
• Health Innovation Manchester: NHS and academic-led health innovation accelerator in the North West of England, supporting early-stage MedTech and digital health companies. Comparable to MTSC in its regional, NHS-and-university-anchored model for health-tech venture acceleration.
• Oxford Foundry: University of Oxford's entrepreneurship centre, supporting student and researcher-led ventures including health and deep tech. Comparable to MTSC as a UK Russell Group university accelerator targeting early-stage ventures from academic research.
• Accelerate Cambridge: Cambridge Judge Business School's startup accelerator supporting founder teams commercialising research. Comparable to MTSC as a UK university-hosted accelerator sharing similar goals of converting deep research into commercial ventures in the Cambridge ecosystem.

Broad incumbents

• JLABS (Johnson & Johnson Innovation): Global life-sciences incubator network operated by Johnson & Johnson, providing lab space, mentorship, and industry access to early-stage MedTech and biotech startups. Directly comparable to MTSC as a multi-site accelerator targeting early-stage medical technology ventures, but operates at global scale under a major pharma sponsor.
• Bayer CoLaborator: Bayer's life-sciences incubator program offering lab space and mentoring to early-stage biotech and MedTech startups. Comparable to MTSC as a corporate-sponsored life sciences accelerator, though larger and backed by a global pharma company.

Others

• MedCity: London-based life sciences cluster organisation supporting investment and growth in the UK MedTech and biotech ecosystem. Comparable to MTSC as a UK life-sciences ecosystem enabler, though focused on cluster-level promotion rather than direct venture acceleration.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/medtech-superconnector

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MedTech SuperConnector